Search details
1.
A selective ER-phagy exerts neuroprotective effects via modulation of α-synuclein clearance in parkinsonian models.
Proc Natl Acad Sci U S A
; 120(37): e2221929120, 2023 09 12.
Article
in English
| MEDLINE | ID: mdl-37669380
2.
Effects of Dihydropyridines on the Motor and Cognitive Outcomes of Patients with Parkinson's Disease.
Mov Disord
; 38(5): 843-853, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36825772
3.
Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease.
Eur J Neurol
; 30(6): 1639-1647, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36915220
4.
Association of cholesterol level with dopamine loss and motor deficits in Parkinson disease: A cross-sectional study.
Eur J Neurol
; 30(1): 107-115, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36209467
5.
Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies.
Brain
; 145(12): 4448-4458, 2022 12 19.
Article
in English
| MEDLINE | ID: mdl-35234856
6.
Differentially targeted seeding reveals unique pathological alpha-synuclein propagation patterns.
Brain
; 145(5): 1743-1756, 2022 06 03.
Article
in English
| MEDLINE | ID: mdl-34910119
7.
Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson's disease.
Brain
; 144(4): 1127-1137, 2021 05 07.
Article
in English
| MEDLINE | ID: mdl-33895825
8.
Effects of statins on dopamine loss and prognosis in Parkinson's disease.
Brain
; 144(10): 3191-3200, 2021 11 29.
Article
in English
| MEDLINE | ID: mdl-34347020
9.
Diffusion tensor imaging-based pontine damage as a degeneration marker in synucleinopathy.
J Neurosci Res
; 99(11): 2922-2931, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34521154
10.
Dopaminergic Depletion, ß-Amyloid Burden, and Cognition in Lewy Body Disease.
Ann Neurol
; 87(5): 739-750, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32078179
11.
White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease.
Mov Disord
; 36(6): 1411-1419, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33513293
12.
Neural correlates of self-awareness of cognitive deficits in non-demented patients with Parkinson's disease.
Eur J Neurol
; 28(12): 4022-4030, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34478599
13.
Motor Cerebellar Connectivity and Future Development of Freezing of Gait in De Novo Parkinson's Disease.
Mov Disord
; 35(12): 2240-2249, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32926481
14.
Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.
Brain
; 142(9): 2845-2859, 2019 09 01.
Article
in English
| MEDLINE | ID: mdl-31312839
15.
Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
Hum Brain Mapp
; 40(13): 3784-3794, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31090134
16.
Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
Eur J Nucl Med Mol Imaging
; 46(8): 1652-1660, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-30980099
17.
Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
J Neurol Neurosurg Psychiatry
; 89(2): 169-174, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28912301
18.
Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.
Eur J Nucl Med Mol Imaging
; 45(3): 423-431, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29075830
19.
The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.
Eur J Nucl Med Mol Imaging
; 45(9): 1585-1595, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29728749
20.
Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.
Alzheimers Dement
; 14(10): 1243-1252, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29936148